SCHEMBL25818060

SCHEMBL25818060

Cc1ccc2c(c1)c(C)cn2CC(C)(C)N

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AR P10275 1/20 0.35
CACNB4 O00305 5/20 0.35
CACNA1A O00555 5/20 0.35
CACNA1G O43497 5/20 0.35
CACNG3 O60359 5/20 0.35
CACNA1F O60840 5/20 0.35
CACNA1H O95180 5/20 0.35
CACNB3 P54284 5/20 0.35
CACNA2D1 P54289 5/20 0.35
CACNG7 P62955 5/20 0.35
CACNA1B Q00975 5/20 0.35
CACNA1D Q01668 5/20 0.35
CACNB1 Q02641 5/20 0.35
CACNG1 Q06432 5/20 0.35
CACNB2 Q08289 5/20 0.35
CACNA1S Q13698 5/20 0.35
CACNA1C Q13936 5/20 0.35
CACNA1E Q15878 5/20 0.35
CACNA2D4 Q7Z3S7 5/20 0.35
CACNA2D3 Q8IZS8 5/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24110219 0.84 AR (0.47) ARKDM4EPTGDR2
SCHEMBL30404688 0.84 AR (0.47) ARKDM4EPTGDR2
SCHEMBL16729587 0.82 PTGDR2 (0.44) ARCACNB4CACNA1ACACNA1GCACNG3
SCHEMBL25818084 0.81 AR (0.34) ARCACNB4CACNA1ACACNA1GCACNG3
SCHEMBL25818008 0.81 CACNB4 (0.34) ARCACNB4CACNA1ACACNA1GCACNG3
SCHEMBL11075326 0.78 CACNB4 (0.39) CACNB4CACNA1ACACNA1GCACNG3CACNA1F
SCHEMBL10165570 0.75 MEN1 (0.44) POLBKDM4EHSD17B10L3MBTL1SLC22A12
Fumaric Acid SCHEMBL27524957 0.75 AR (0.48) ARKDM4EHSD17B10THRATHRB
SCHEMBL13539150 0.72 PGR (0.48) CNR2
SCHEMBL25819171 0.72 HTR2C (0.58) HTR2AHTR2CMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230219969-A1 ISOTRYPTAMINE PSYCHOPLASTOGENS AND USES THEREOF DELIX THERAPEUTICS, INC. 2023-07-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230219969-A1 ISOTRYPTAMINE PSYCHOPLASTOGENS AND USES THEREOF GAP43, SLC18A2, PNMT AR 2350/4885CACNB4 1528/4885CACNA1A 1973/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.